Fibrosis drug may offer new treatment path for COVID-19 lung distress
Sunday, April 5, 2020 - 11:10
in Health & Medicine
A new drug for lung fibrosis that Yale pulmonologist Dr. Naftali Kaminski began developing a few years ago shows promise for treating certain life-threatening effects of COVID-19, and his research team is rapidly laying the groundwork for clinical trials. In lung fibrosis, the drug, called sobetirome, mimics the effects of thyroid hormone therapy, which heals […]